平禽律疫苗

Country: Թայվան

language: չինարեն

source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

PIL PIL (PIL)
16-06-2020
PAR PAR (PAR)
16-06-2020

active_ingredient:

Purified antigen fractions of inactivated split virions A/Indonesia/05/2005 (H5N1) PR8-IBCDC-RG2;;SQUALENE;;TOCOPHEROL ALPHA DL- (EQ TO DL-ALPHA TOCOPHEROL);;TWEEN 80 (EQ TO POLYSORBATE 80)

MAH:

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438)

ATC_code:

J07BB02

pharmaceutical_form:

懸浮注射劑

composition:

Purified antigen fractions of inactivated split virions A/Indonesia/05/2005 (H5N1) PR8-IBCDC-RG2 (8012006700) ug HA; TOCOPHEROL ALPHA DL- (EQ TO DL-ALPHA TOCOPHEROL) (8820000113) MG; TWEEN 80 (EQ TO POLYSORBATE 80) (9600023580) MG; SQUALENE (9600030000) MG

units_in_package:

小瓶裝

class:

菌 疫

prescription_type:

須由醫師處方使用

manufactured_by:

GLAXOSMITHKLINE BIOLOGICALS S.A. 89 RUE DE L'INSTITUT 1330 RIXENSART, BELGIUM BE

therapeutic_area:

influenza, inactivated, split virus or surface antigen

therapeutic_indication:

用於18歲(含)以上的成人主動免疫接種,以預防H5N1病毒株所引起的流感。

leaflet_short:

註銷日期: 2021/01/18; 註銷理由: 自請註銷; 有效日期: 2021/03/08; 英文品名: Prepandrix TM

authorization_status:

已註銷

authorization_date:

2011-03-08